Lisanti Capital Growth LLC Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Lisanti Capital Growth LLC acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, HoldingsChannel.com reports. The firm acquired 152,445 shares of the company’s stock, valued at approximately $4,502,000.

Several other institutional investors and hedge funds also recently made changes to their positions in ACHC. BlackRock Inc. bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth about $441,685,000. Wellington Management Group LLP lifted its holdings in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after buying an additional 3,815,471 shares in the last quarter. UBS Group AG grew its stake in Acadia Healthcare by 8.8% during the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after buying an additional 350,484 shares during the last quarter. Finally, Jefferies Financial Group Inc. bought a new stake in Acadia Healthcare during the fourth quarter worth about $47,960,000.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Royal Bank Of Canada lifted their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. KeyCorp lifted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. Finally, Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the company from $24.50 to $30.00 in a research note on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $27.36 on Thursday. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm’s 50 day moving average is $29.86 and its 200-day moving average is $25.39. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of -2.20, a PEG ratio of 8.89 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same quarter last year, the business posted $0.83 earnings per share. Acadia Healthcare’s revenue for the quarter was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.